(RTTNews) - Cyclo Therapeutics, Inc. (CYTH) on Friday announced promising preliminary data from its ongoing Phase 3 TransportNPC study, evaluating Trappsol Cyclo for the treatment of Niemann-Pick ...
SimActive adds support for Phase One’s iXM-FS130 in Correlator3D, enabling 1 cm aerial imagery processing for high-resolution mapping.
Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results